.Merck & Co.'s long-running initiative to land a blow on little mobile bronchi cancer cells (SCLC...
.Some patients with non-small cell lung cancer cells (NSCLC) possess anomalies in a gene named indiv...
.MBX has actually fleshed out programs to enjoy over $136 thousand coming from its own IPO as the bi...
.Relay Therapies has beaten its survival objective in a first-in-human boob cancer study, placing th...
.AstraZeneca has used expert system to design a special biomarker for its own Daiichi Sankyo-partner...
.AstraZeneca managers claim they are "certainly not stressed" that the breakdown of tozorakimab in a...
.Invite to today's Chutes & Ladders, our summary of substantial leadership hirings, shootings and...
.After showing programs to strike the U.S. public markets less than a month back, Zenas Biopharma an...
.Psyence Biomedical is actually paying $500,000 in shares to acquire fellow psilocybin-based biotech...
.Five months after approving Electrical Therapeutics' Pivya as the first brand new therapy for strai...